Perspectives of drug-based neuroprotection targeting mitochondria

Revue Neurologique

Volumn 170, Issue 5, 2014, Pages 390-400

  Procaccio, V ^a   Bris, C ^a   Chao De La Barca, J M ^a   Oca, F ^a   Chevrollier, A ^a   Amati Bonneau, P ^a   Bonneau, D ^a   Reynier, P ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Mitochondria; Mitochondrial diseases; Neurodegenerative disorders; Pharmacological neuroprotection

Indexed keywords

FREE RADICAL; MITOCHONDRIAL DNA; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; BIOGENESIS; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; KETOGENIC DIET; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RESPIRATORY CHAIN; ANIMAL; CELL PROTECTION; DRUG EFFECTS; MITOCHONDRIAL DISEASES; MOLECULARLY TARGETED THERAPY; NERVE CELL; NEURODEGENERATIVE DISEASES; PROCEDURES;

ANIMALS; CYTOPROTECTION; HUMANS; MITOCHONDRIAL DISEASES; MOLECULAR TARGETED THERAPY; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 84901241148     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2014.03.005     Document Type: Article

References (63)

1. D.C. Wallace, M.T. Lott, and V. Procaccio Mitochondrial medicine: the mitochondrial biology and genetics of metabolic and degenerative diseases, cancer, and aging. Emery and Rimoin's principle and practice of medical genetics 6th ed. 2013 Elsevier editors Waltham, MA, USA 1 153 [Chapter 11]
2. D.C. Wallace, W. Fan, and V. Procaccio Mitochondrial energetics and therapeutics Ann Rev Pathol 5 2010 297 348
3. D.S. Kerr Review of clinical trials for mitochondrial disorders: 1997-2012 Neurotherapeutics 10 2 2013 307 319
4. G. Pfeffer, K. Majamaa, D.M. Turnbull, D. Thorburn, and P.F. Chinnery Treatment for mitochondrial disorders Cochrane Database Syst Rev 4 2012 CD004426
5. P. Bernardi, and A. Rasola Calcium and cell death: the mitochondrial connection Subcell Biochem 45 2007 481 506
6. A.M. Schaefer, R. McFarland, E.L. Blakely, L. He, R.G. Whittaker, and R.W. Taylor et al. Prevalence of mitochondrial DNA disease in adults Ann Neurol 63 1 2008 35 39
7. E. Ruiz-Pesini, M.T. Lott, V. Procaccio, J.C. Poole, M.C. Brandon, and D. Mishmar et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny Nucleic Acids Res 35 2007 D823 D828 [Database issue]
8. W.J. Koopman, P.H. Willems, and J.A. Smeitink Monogenic mitochondrial disorders N Engl J Med 366 12 2012 1132 1141
9. A. Rotig, E.L. Appelkvist, V. Geromel, D. Chretien, N. Kadhom, and P. Edery et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency Lancet 356 9227 2000 391 395
10. C.M. Quinzii, M. Hirano, and S. DiMauro CoQ10 deficiency diseases in adults Mitochondrion 7 Suppl. 2007 S122 S126
11. T. Meier, S.L. Perlman, C. Rummey, N.J. Coppard, and D.R. Lynch Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study J Neurol 259 2 2012 284 291
12. T. Klopstock, P. Yu-Wai-Man, K. Dimitriadis, J. Rouleau, S. Heck, and M. Bailie et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy Brain 134 Pt. 9 2011 2677 2686
13. V. Carelli, C. La Morgia, M.L. Valentino, G. Rizzo, M. Carbonelli, and A.M. De Negri et al. Idebenone treatment in Leber's hereditary optic neuropathy Brain 134 Pt. 9 2011 e188
14. D. Martinelli, M. Catteruccia, F. Piemonte, A. Pastore, G. Tozzi, and C. Dionisi-Vici et al. EPI-743 reverses the progression of the pediatric mitochondrial disease - genetically defined Leigh syndrome Mol Genet Metab 107 3 2012 383 388
15. A.A. Sadun, C.F. Chicani, F.N. Ross-Cisneros, P. Barboni, M. Thoolen, and W.D. Shrader et al. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy Arch Neurol 69 3 2012 331 338
16. C. Giordano, L. Iommarini, L. Giordano, A. Maresca, A. Pisano, and M.L. Valentino et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy Brain 137 2014 335 353
17. I. Kim, S. Rodriguez-Enriquez, and J.J. Lemasters Selective degradation of mitochondria by mitophagy Arch Biochem Biophys 462 2 2007 245 253
18. R.R. Thomas, S.M. Khan, R.M. Smigrodzki, I.G. Onyango, J. Dennis, and O.M. Khan et al. RhTFAM treatment stimulates mitochondrial oxidative metabolism and improves memory in aged mice Aging (Albany NY) 4 9 2012 620 635
19. M. Tomasetti, J. Neuzil, and L. Dong MicroRNAs as regulators of mitochondrial function: role in cancer suppression Biochim Biophys Acta 184 4 2014 1441 1453
20. R.K. Chaturvedi, and M. Flint Beal Mitochondrial diseases of the brain Free Radic Biol Med 63 2013 1 29
21. J. Zhu, K.Z. Wang, and C.T. Chu After the banquet: mitochondrial biogenesis, mitophagy, and cell survival Autophagy 9 11 2013 1663 1676
22. L. Cui, H. Jeong, F. Borovecki, C.N. Parkhurst, N. Tanese, and D. Krainc Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration Cell 127 1 2006 59 69
23. L. Katsouri, C. Parr, N. Bogdanovic, M. Willem, and M. Sastre PPARgamma co-activator-1alpha (PGC-1alpha) reduces amyloid-beta generation through a PPARgamma-dependent mechanism J Alzheimers Dis 25 1 2011 151 162
24. S. Da Cruz, P.A. Parone, V.S. Lopes, C. Lillo, M. McAlonis-Downes, and S.K. Lee et al. Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS Cell Metab 15 5 2012 778 786
25. S.D. Chen, T.K. Lin, D.I. Yang, S.Y. Lee, F.Z. Shaw, and C.W. Liou et al. Protective effects of peroxisome proliferator-activated receptors gamma coactivator-1alpha against neuronal cell death in the hippocampal CA1 subfield after transient global ischemia J Neurosci Res 88 3 2010 605 613
26. J. St-Pierre, S. Drori, M. Uldry, J.M. Silvaggi, J. Rhee, and S. Jager et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators Cell 127 2 2006 397 408
27. Q. Wang, Y. Zhang, C. Yang, H. Xiong, Y. Lin, and J. Yao et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux Science 327 5968 2010 1004 1007
28. E. Verdin, M.D. Hirschey, L.W. Finley, and M.C. Haigis Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling Trends Biochem Sci 35 12 2010 669 675
29. G. Donmez, D. Wang, D.E. Cohen, and L. Guarente SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10 Cell 142 2 2010 320 332
30. T.F. Outeiro, E. Kontopoulos, S.M. Altmann, I. Kufareva, K.E. Strathearn, and A.M. Amore et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease Science 317 5837 2007 516 519
31. S.H. Kim, H.F. Lu, and C.C. Alano Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture PLoS One 6 3 2011 e14731
32. J.S. Won, Y.B. Im, J. Kim, A.K. Singh, and I. Singh Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis Biochem Biophys Res Commun 399 4 2010 487 491
33. P.A. Andreux, R.H. Houtkooper, and J. Auwerx Pharmacological approaches to restore mitochondrial function Nat Rev Drug Discov 12 6 2013 465 483
34. S. Timmers, E. Konings, L. Bilet, R.H. Houtkooper, T. van de Weijer, and G.H. Goossens et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans Cell Metab 14 5 2011 612 622
35. J. Fu, J. Jin, R.H. Cichewicz, S.A. Hageman, T.K. Ellis, and L. Xiang et al. trans-(-)-epsilon-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease J Biol Chem 287 29 2012 24460 24472
36. V. Desquiret-Dumas, N. Gueguen, G. Leman, S. Baron, V. Nivet-Antoine, and S. Chupin et al. Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells J Biol Chem 288 51 2013 36662 36675
37. A.P. Gomes, N.L. Price, A.J. Ling, J.J. Moslehi, M.K. Montgomery, and L. Rajman et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging Cell 155 7 2013 1624 1638
38. A. Johri, N.Y. Calingasan, T.M. Hennessey, A. Sharma, L. Yang, and E. Wille et al. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease Hum Mol Genet 21 5 2012 1124 1137
39. N. Noe, L. Dillon, V. Lellek, F. Diaz, A. Hida, and C.T. Moraes et al. Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy Mitochondrion 13 5 2013 417 426
40. J.M. Zolezzi, C. Silva-Alvarez, D. Ordenes, J.A. Godoy, F.J. Carvajal, and M.J. Santos et al. Peroxisome proliferator-activated receptor (PPAR) gamma and PPARalpha agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders? PLoS One 8 5 2013 e64019
41. D.C. Chan Fusion and fission: interlinked processes critical for mitochondrial health Annu Rev Genet 46 2012 265 287
42. Z. Li, K. Okamoto, Y. Hayashi, and M. Sheng The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses Cell 119 6 2004 873 887
43. M.A. Perez-Pinzon, R.A. Stetler, and G. Fiskum Novel mitochondrial targets for neuroprotection J Cereb Blood Flow Metab 32 7 2012 1362 1376
44. K. Itoh, K. Nakamura, M. Iijima, and H. Sesaki Mitochondrial dynamics in neurodegeneration Trends Cell Biol 23 2 2013 64 71
45. R.J. Youle, and A.M. van der Bliek Mitochondrial fission, fusion, and stress Science 337 6098 2012 1062 1065
46. M. Karbowski, and A. Neutzner Neurodegeneration as a consequence of failed mitochondrial maintenance Acta Neuropathol 123 2 2012 157 171
47. S.M. Jin, M. Lazarou, C. Wang, L.A. Kane, D.P. Narendra, and R.J. Youle Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL J Cell Biol 191 5 2010 933 942
48. S. Campello, F. Strappazzon, and F. Cecconi Mitochondrial dismissal in mammals, from protein degradation to mitophagy Biochim Biophys Acta 1837 4 2014 451 460
49. N.T. Hertz, A. Berthet, M.L. Sos, K.S. Thorn, A.L. Burlingame, and K. Nakamura et al. A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1 Cell 154 4 2013 737 747
50. H. Harris, and D.C. Rubinsztein Control of autophagy as a therapy for neurodegenerative disease Nat Rev Neurol 8 2 2012 108 117
51. Y. Dai, K. Zheng, J. Clark, R.H. Swerdlow, S.M. Pulst, and J.P. Sutton et al. Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation Hum Mol Genet 23 3 2013 637 647
52. S.C. Johnson, M.E. Yanos, E.B. Kayser, A. Quintana, M. Sangesland, and A. Castanza et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome Science 342 6165 2013 1524 1528
53. Y. Koga, N. Povalko, J. Nishioka, K. Katayama, N. Kakimoto, and T. Matsuishi MELAS and L-arginine therapy: pathophysiology of stroke-like episodes Ann N Y Acad Sci 1201 2010 104 110
54. Y. Koga, Y. Akita, J. Nishioka, S. Yatsuga, N. Povalko, and K. Katayama et al. MELAS and L-arginine therapy Mitochondrion 7 1-2 2007 133 139
55. Y. Koga, Y. Akita, N. Junko, S. Yatsuga, N. Povalko, and R. Fukiyama et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation Neurology 66 11 2006 1766 1769
56. Y. Goto, I. Nonaka, and S. Horai A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies Nature 348 6302 1990 651 653
57. G. Pfeffer, R. Horvath, T. Klopstock, V.K. Mootha, A. Suomalainen, and S. Koene et al. New treatments for mitochondrial disease-no time to drop our standards Nat Rev Neurol 9 8 2013 474 481
58. C.E. Stafstrom, and J.M. Rho The ketogenic diet as a treatment paradigm for diverse neurological disorders Front Pharmacol 3 2012 59
59. H.C. Kang, Y.M. Lee, H.D. Kim, J.S. Lee, and A. Slama Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects Epilepsia 48 1 2007 82 88
60. S. Santra, R.W. Gilkerson, M. Davidson, and E.A. Schon Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells Ann Neurol 56 5 2004 662 669
61. J. Yao, S. Chen, Z. Mao, E. Cadenas, and R.D. Brinton 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease PLoS One 6 7 2011 e21788
62. L. Guarente Calorie restriction and sirtuins revisited Genes Dev 27 19 2013 2072 2085
63. L.P. Wills, G.C. Beeson, R.E. Trager, C.C. Lindsey, C.C. Beeson, and Y.K. Peterson et al. High-throughput respirometric assay identifies predictive toxicophore of mitochondrial injury Toxicol Appl Pharmacol 272 2 2013 490 502